Treatment Option for Two Subsets of Challenging to Treat Major Depressive Disorder in Adults
The latest IDGA webinar looks at treatment plans for the VA's adult patients with two subtypes of major depressive disorder (MDD).
There continues to be a growing prevalence of mental health needs in the Veterans Health Administration (VHA). Specifically, there is a significant unmet need in adult patients with 2 subtypes of major depressive disorder (MDD).
On behalf of Janssen Pharmaceuticals, Inc., join Dr. Sanjai Rao, an associate clinical professor of psychiatry at the University of California, San Diego, and an attending psychiatrist at the VA medical center in San Diego, to learn about a treatment option that is approved to treat adults with two subsets of challenging to treat MDD.
The promotional program entitled “Treatment Option for Two Subsets of Challenging to Treat Major Depressive Disorder (MDD) in Adults” will specifically focus on the following:
• Unmet need in adult patients with challenging to treat MDD
• Patient population, efficacy data, and dosing and administration overview
• Considerations for establishing a treatment center
We look forward to welcoming you to this webinar
